SynthesisClinical and experimental medicine2023

Venetoclax combined with hypomethylating agents or low-dose cytarabine as induction chemotherapy for patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review and meta-analysis.

Yao Qin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.